FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
FutureFemHealth Pro
Archive
About
💌 Issue 147: UroMems' $60m | Evvy's AI advisor | Microbiome trial for preterm birth prevention
The global weekly briefing on women's health innovation and Femtech
 • Anna O'Sullivan
How women’s health branding grew up
Why the fastest-growing brands in women’s health are combining clinical credibility, consumer-grade design and unapologetic honesty
 • Anna O'Sullivan
Evvy launches AI advisor built on vaginal microbiome data
Uses data from more than 100,000 tests
 • Anna O'Sullivan
Why women’s health is building a new ‘trust layer’
Startups, standards and AI platforms are building the systems shaping how women discover, evaluate and trust health information
 • Anna O'Sullivan
💌 Issue 146: PCOS renamed PMOS | AI consortium launch | ŌURA partners on women's health | Calla Lily doses first patients
The global weekly briefing on women's health innovation and Femtech
 • Anna O'Sullivan
Behind the scenes of the FutureFemHealth rebrand
I’ve been working with the team at BOLD LIP - a female-founded creative agency specialising in women’s health branding
 • Anna O'Sullivan
Women’s health leaders launch AI consortium to set standards for the sector
Raising bar for clinically safe, culturally aware, and female-centred design
 • Anna O'Sullivan
PCOS renamed PMOS after 14-year global push to reframe the condition
Polycystic Ovary Syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS)
 • Anna O'Sullivan
The women suffering through anorectal pain - and too embarrassed to ask for help
New research suggests stigma and poor education are leaving women with hemorrhoids and anal fissures to suffer in silence - especially after childbirth.
 • Anna O'Sullivan
Women dismissed by healthcare professionals are turning to AI and social media for health advice, report finds
New research highlights how pain dismissal is pushing women toward alternative health information sources - particularly among younger generations.
 • Anna O'Sullivan
Calla Lily Clinical Care doses first patients in miscarriage treatment trial
Evaluating new intravaginal drug delivery platform for progesterone treatment
 • Anna O'Sullivan
💌 Issue 145: ŌURA doubles down on women’s health | Hinge Health moves into migraine | mental health and women's health | Omaia pre-seed…
The global weekly briefing on women's health innovation and Femtech
 • Anna O'Sullivan
© 2026 FutureFemHealth Ltd · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture